Table 1.

Studies of the cost of congenital rubella syndrome

First author [Reference]	de Owens [[15]]	Robinson [[16]]	Lanzieri [[14]]	Al-Awaidy [[13]]
Country	Panama	Jamaica	Brazil	Oman
Year	1989	1998	2004	2006
WB income group	Upper middle	Upper middle	Upper middle	High
Perspective	Health system*	Health system*	Health system	Societal
Cost components measured	NR	NR	Diagnosis; OP care; Hospitalization Surgery; 1st year of FU	Diagnosis; OP care; Hospitalization Surgery; Drugs; Equipment; Special schools; Indirect costs
Method of cost estimation	NR	NR	Micro-costing using reimbursement data	Micro-costing using accounts data (treatment costs); Human capital approach (for indirect costs)
Time period for costing	Annual	Annual	Annual (1st year)	Lifetime
Discounting (Rate)	NA	NA	NA	Yes (3%)
Results (2012 US$)	$58,023	$57,010	$4,261	$139,910
Sponsor	NR	NR	NR	Oman MOH*

*Not explicitly reported but inferred.

WB, World Bank; NR, Not Reported; NA, Not Applicable; OP, Out-Patient; FU, Follow-Up; CRS, Congenital Rubella Syndrome; MOH, Ministry of Health.